MHRA-102302-PIP01-26

Key Facts

Active Substance
Active Substance:
  • mRNA encoding Influenza A, subtype H5N1, strain A/chicken/Ghana/2021, haemagglutinin
Invented Name
Not yet available
PIP Number MHRA-102302-PIP01-26
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Dispersion for injection
Therapeutic area
  • Vaccines
  • Other: mRNA vaccine
Conditions / Indications
Conditions / Indications:
  • Prevention of pandemic influenza
Route(s) of administration
Route(s) of administration:
  • Intramuscular use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):mRNA encoding Influenza A, subtype H5N1, strain A/chicken/Ghana/2021, haemagglutinin .pdf
Published Date 03/07/2026